De-O-methyllasiodiplodin

De-O-methyllasiodiplodin
Product Name De-O-methyllasiodiplodin
CAS No.: 32885-82-8
Catalog No.: CFN96880
Molecular Formula: C16H22O4
Molecular Weight: 278.34 g/mol
Purity: >=98%
Type of Compound: Phenols
Physical Desc.: Oil
Targets: IL Receptor | TNF-α | ROS | NO | Antifection
Source: The rhizomes of Smilax glabra.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
De-O-methyllasiodiplodin exhibits radical scavenging, moderate antibacterial, and potential anti-inflammatory effects, it shows moderate suppression effects on induced NO production. De-O-methyllasiodiplodin effectively lowers the blood glucose level in db/db mice possibly via ameliorating the expression of obesity-related pro-inflammatory cytokines, highlighting the potential of the marine natural product as a drug lead for the treatment of metabolic disorders.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Vojnosanit Pregl2016, 75(00):391-391
  • Evid Based Complement Alternat Med.2016, 2016:4357656
  • Psychopharmacology (Berl).2020, 10.1007
  • Evid-Based Compl Alt2020, 7202519:13
  • Nutrients.2024, 16(14):2267.
  • Front Pharmacol.2021, 12:761922.
  • Recent Pat Anticancer Drug Discov.2022, 17(4):416-426.
  • Food Chem.2024, 452:139555.
  • Arch Biochem Biophys.2020, 687:108384.
  • Biosci. Rep.2020, 10.1024
  • Aloin B

    Catalog No: CFN90434
    CAS No: 28371-16-6
    Price: $138/20mg
    Physalin B

    Catalog No: CFN92941
    CAS No: 23133-56-4
    Price: Inquiry(manager@chemfaces.com)
    Tilianin

    Catalog No: CFN92764
    CAS No: 4291-60-5
    Price: $218/20mg
    Capsanthin

    Catalog No: CFN70366
    CAS No: 465-42-9
    Price: Inquiry(manager@chemfaces.com)
    p-Hydroxy-cinnamic acid

    Catalog No: CFN98179
    CAS No: 7400-08-0
    Price: $70/20mg
    Acta Pharmacol Sin. 2013 Oct;34(10):1325-36.
    Marine natural product des-O-methyllasiodiplodin effectively lowers the blood glucose level in db/db mice via ameliorating inflammation.[Pubmed: 23852084 ]
    des-O-methyllasiodiplodin (De-O-methyllasiodiplodin,DML) from Cerbera manghas has shown antagonistic activity against mineralocorticoid receptor (MR). Considering the involvement of MR in the insulin tolerance, we attempted to investigate the potential of DML in the treatment of type 2 diabetes mellitus (T2DM).
    METHODS AND RESULTS:
    In HepG2 and 3T3-L1 cells, both H2O2 and aldosterone markedly stimulates the expression of MCP-1, TNFα, IL-6, p47 and PU.1 genes. Co-treatment with DML (10 μmol/L) significantly reduced the H2O2- or aldosterone-induced expression of these genes. SPR-based assay confirmed the antagonistic activity of DML against the interaction between SRC-1 and MR-LBD. Furthermore, DML decreased aldosterone-induced MR transcriptional activity in a dose-dependent manner. Downregulation of MR with siRNA in the cells prevented or significantly attenuated aldosterone-stimulated expression of these genes, whereas DML did no longer affect the expression of these genes except that of IL-6. Oral administration of DML effectively reduced the levels of blood glucose and glycosylated hemoglobin (HbA1c) in db/db mice. The treatment also rectified the expression of pro-inflammatory factor and ROS-related genes in db/db mice.
    CONCLUSIONS:
    DML effectively lowers the blood glucose level in db/db mice possibly via ameliorating the expression of obesity-related pro-inflammatory cytokines, highlighting the potential of the marine natural product as a drug lead for the treatment of metabolic disorders.
    Nat Prod Res. 2016;30(5):565-9.
    A new sesquiterpenoid quinone with cytotoxicity from Abelmoschus sagittifolius.[Pubmed: 26230217 ]

    METHODS AND RESULTS:
    A new sesquiterpenoid quinone, Acyl hibiscone B (1), together with five known compounds, (R)-lasiodiplodin (2), (R)-De-O-methyllasiodiplodin, (3) dibutyl phthalate (4), (R)-9-phenylnonan-2-ol (5) and hibiscone B (6), was obtained from the stem tuber of Abelmoschus sagittifolius. The structure of compound 1 was elucidated by analysing its (1)H and (13)C NMR, (1)H-(1)H COSY, HSQC, HMBC, NOESY and HR-ESI-MS values.
    CONCLUSIONS:
    Compound 1 showed significant cytotoxicity against Hela and HepG-2 human cancer cell lines.
    Nat Prod Res. 2014;28(15):1210-3.
    Chemical constituents from Gouania longipetala and Glyphaea brevis.[Pubmed: 24910899 ]

    METHODS AND RESULTS:
    Five compounds were isolated altogether from the two medicinal plants. Glycerol monotricosanoate (1), palmarumycin BG1 (2) and De-O-methyllasiodiplodin (3) were isolated from Gouania longipetala. In addition, epicatechin (4) and its dimer procyanidin B2 (5) were isolated from the stem bark of Glyphaea brevis. Their structures were elucidated by using spectroscopic experiments.
    CONCLUSIONS:
    They exhibited radical scavenging and moderate antibacterial effects.
    Apterin

    Catalog No: CFN95005
    CAS No: 53947-89-0
    Price: $388/10mg
    8,8''-Bibaicalein

    Catalog No: CFN95007
    CAS No: 135309-02-3
    Price: $318/5mg
    Maculosidin

    Catalog No: CFN95126
    CAS No: 522-19-0
    Price: $413/5mg
    New compound 3

    Catalog No: CFN95184
    CAS No: N/A
    Price: $368/5mg
    Astin B

    Catalog No: CFN95188
    CAS No: 151201-76-2
    Price: $318/10mg
    (3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol

    Catalog No: CFN95195
    CAS No: 87095-75-8
    Price: $318/5mg
    Neoarctin B

    Catalog No: CFN95243
    CAS No: 155969-67-8
    Price: $318/10mg
    Eschweilenol C

    Catalog No: CFN95363
    CAS No: 211371-02-7
    Price: $318/10mg
    New compound 13

    Catalog No: CFN95374
    CAS No: N/A
    Price: $318/5mg
    Murracarpin

    Catalog No: CFN95409
    CAS No: 120786-76-7
    Price: $413/5mg